Lung Cancer Rx

What Do ASCO 2026 Data on NSCLC Co-mutations Mean for Practice?

31 min · 12. juni 2026
episode What Do ASCO 2026 Data on NSCLC Co-mutations Mean for Practice? cover

Description

Ferdinandos Skoulidis, MD, PhD, discusses data on KRAS- mutated NSCLC from ASCO 2026 with Aakash Desai, MD, MPH, Fawzi F. Abu Rous, MD, and Eric K. Singhi, MD.

Comments

0

Be the first to comment

Sign up now and become a member of the Lung Cancer Rx community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

12 episodes